Overview

Full Product Details

Author:   Jeffrey Laurence (Weill Cornell Medical College, New York, NY, USA)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Dimensions:   Width: 15.20cm , Height: 2.50cm , Length: 22.90cm
Weight:   0.770kg
ISBN:  

9780128005538

ISBN 10:   012800553
Pages:   392
Publication Date:   04 October 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Introduction to microRNAs (Monty Montano) 2. MicroRNA targets for cancer therapy (Carlo Croce, MD) 3. MicroRNAs as Targets for Lung Cancer Therapy and Prevention (Ethan Dmitrovsky, M.D.) 4. MicroRNAs as biomarkers in lung cancer: miracle or quagmire? (Robert Kratzke, MD) 5. MicroRNAs in inflammatory lung disease (Joe GN Garcia MD) 6. MicroRNAs and lung fibrosis (Naftali Kaminski MD) 7. MicroRNAs and diabetes (Romano Regazzi, PhD) 8. MicroRNAs and liver disease (Nicholas O. Davidson, MD; Kevin Korenblat, MD; Tom Kerr, MD, PhD) 9. MicroRNAs and cardiovascular disease (Gerald Dorn, MD) 10. MicroRNAs and diabetic nephropathy and vascular disease in kidney tissue (Bryan Becker, MD) 11. MicroRNAs and autoimmunity (Ansar Ahmed, DVM, PhD) 12. MicroRNAs and neurodegenerative diseases (Edgardo Rodriguez-Lebron, PhD) 13. MicroRNAs in viral hepatitis (TBA)

Reviews

Author Information

Dr Laurence is pursuing the pathophysiology of cardiovascular and skeletal abnormalities linked to HIV disease and its therapies at Weill Cornell. Dr Laurence is the editor-in-chief of Translational Medicine, which Elsevier co-publishes with the CSCTR.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions